Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX - Get Free Report) shares saw unusually-high trading volume on Friday . Approximately 36,265 shares traded hands during trading, an increase of 37% from the previous session's volume of 26,468 shares.The stock last traded at $14.30 and had previously closed at $16.15.
Analyst Upgrades and Downgrades
Several research analysts recently commented on the company. William Blair reiterated an "outperform" rating on shares of Telix Pharmaceuticals Limited American Depositary Shares in a research note on Wednesday, March 12th. UBS Group lifted their price objective on Telix Pharmaceuticals Limited American Depositary Shares from $21.00 to $22.00 and gave the stock a "buy" rating in a report on Monday, January 27th.
Read Our Latest Stock Report on Telix Pharmaceuticals Limited American Depositary Shares
Telix Pharmaceuticals Limited American Depositary Shares Stock Performance
The business's fifty day simple moving average is $17.55.
Telix Pharmaceuticals Limited American Depositary Shares Company Profile
(
Get Free Report)
Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals.
See Also
Before you consider Telix Pharmaceuticals Limited American Depositary Shares, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Telix Pharmaceuticals Limited American Depositary Shares wasn't on the list.
While Telix Pharmaceuticals Limited American Depositary Shares currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
